IC
TEVA icon

IEQ Capital’s Teva Pharmaceuticals TEVA Stock Holding History

IEQ Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Sell
41,170
-1,363
-3% -$45.4K 0.01% 971
2026
Q1 		$1.28M Buy
42,533
+707
+2% +$22.7K 0.01% 936
2025
Q4 		$1.31M Buy
41,826
+6,201
+17% +$153K ﹤0.01% 934
2025
Q3 		$720K Buy
+35,625
New +$626K ﹤0.01% 1141
2023
Q3 		– Sell
-100,404
Closed -$756K – 965
2023
Q2 		$756K Buy
100,404
+404
+0.4% +$3.28K 0.02% 456
2023
Q1 		$885K Buy
+100,000
New +$989K 0.02% 418

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

IEQ Capital's TEVA Position: Q2 2026 in Review

IEQ Capital reduced its Teva Pharmaceuticals (TEVA) stake by 3.2% in Q2 2026, selling an estimated $45.4K and leaving 41,170 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #971.

IEQ Capital first reported a position in TEVA in Q1 2023 and has held it in 6 quarters since. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • IEQ Capital held 41,170 shares of Teva Pharmaceuticals worth $1.39M as of Q2 2026.
  • IEQ Capital sold 1,363 Teva Pharmaceuticals shares in Q2 2026, an estimated $45.4K.
  • Teva Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #971 holding.
  • IEQ Capital first reported a position in Teva Pharmaceuticals in Q1 2023 and has held it in 6 quarters since.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.